Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PATISIRAN for Polyneuropathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 36 adverse event reports in the FDA FAERS database where PATISIRAN was used for Polyneuropathy.

Most Reported Side Effects for PATISIRAN

Side Effect Reports % Deaths Hosp.
Death 250 9.2% 250 33
Product dose omission issue 175 6.5% 11 113
Fatigue 165 6.1% 3 46
Infusion related reaction 134 5.0% 0 29
Hospitalisation 127 4.7% 8 127
Asthenia 108 4.0% 8 48
Fall 107 4.0% 3 65
Intentional dose omission 107 4.0% 6 65
Cardiac failure 95 3.5% 26 65
Dyspnoea 87 3.2% 10 54
Malaise 82 3.0% 6 35
Inappropriate schedule of product administration 80 3.0% 5 49
Diarrhoea 78 2.9% 2 31
Nausea 78 2.9% 3 35
Therapy interrupted 73 2.7% 5 57

Other Indications for PATISIRAN

Hereditary neuropathic amyloidosis (1,849) Product used for unknown indication (569) Amyloidosis (111) Amyloidosis senile (91) Cardiac amyloidosis (56) Acquired attr amyloidosis (17) Cardiomyopathy (7) Familial amyloidosis (7)

Other Drugs Used for Polyneuropathy

PREGABALIN (884) HUMAN IMMUNOGLOBULIN G (529) GABAPENTIN (180) INOTERSEN (62) RITUXIMAB (56) DULOXETINE (45) LENALIDOMIDE (42) EPLONTERSEN (21) CLONAZEPAM (17) METAMIZOLE (16)

Related Pages

PATISIRAN Full Profile All Polyneuropathy Drugs PATISIRAN Demographics PATISIRAN Timeline